PMA

P090013: REVO MRI SURESCAN IPG AND PACING SYSTEM

FDA PMA · Implantable pulse generator, pacemaker (non-CRT) · Medtronic, Inc.

Key facts

PMA number P090013
Trade name REVO MRI SURESCAN IPG AND PACING SYSTEM
Generic name Implantable pulse generator, pacemaker (non-CRT)
Applicant Medtronic, Inc.
Owner/operator Medtronic, Inc.
Product code LWP
Approval date Feb 8, 2011
Docket number 11M-0105
Notice date Feb 24, 2011
Establishment registration 2182208
FEI number 2182208

At a glance

  • 100–999 Supplements
  • Jun 5, 2025 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals